Showing 1 - 8 results of 8 for search 'Vladimír Šubr', query time: 0.03s Refine Results
  1. 1
    Singlet Oxygen In Vivo: It Is All about Intensity

    Singlet Oxygen In Vivo: It Is All about Intensity by Steffen Hackbarth, Rayhanul Islam, Vladimír Šubr, Tomáš Etrych, Jun Fang

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Highly Effective Synthetic Polymer-Based Blockers of Non-Specific Interactions in Immunochemical Analyses

    Highly Effective Synthetic Polymer-Based Blockers of Non-Specific Interactions in Immunochemical Analyses by Vladimír Šubr, Libor Kostka, Jan Plicka, Ondřej Sedláček, Tomáš Etrych

    Published 2024-03-01
    Get full text
    Article
  3. 3
    Singlet Oxygen <i>In Vivo</i>: It Is All about Intensity—Part 2

    Singlet Oxygen <i>In Vivo</i>: It Is All about Intensity—Part 2 by Steffen Hackbarth, Shanghui Gao, Vladimír Šubr, Lisheng Lin, Jakob Pohl, Tomáš Etrych, Jun Fang

    Published 2023-04-01
    Get full text
    Article
  4. 4
    Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents

    Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents by Jun Fang, Rayhanul Islam, Waliul Islam, Hongzhuan Yin, Vladimir Subr, Tomas Etrych, Karel Ulbrich, Hiroshi Maeda

    Published 2019-07-01
    Get full text
    Article
  5. 5
    Effect of Intratumoral Injection on the Biodistribution, the Therapeutic Potential of HPMA Copolymer-Based Drug Delivery Systems

    Effect of Intratumoral Injection on the Biodistribution, the Therapeutic Potential of HPMA Copolymer-Based Drug Delivery Systems by Twan Lammers, Peter Peschke, Rainer Kühnlein, Vladimir Subr, Karel Ulbrich, Peter Huber, Wim Hennink, Gert Storm

    Published 2006-10-01
    Get full text
    Article
  6. 6
    Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines

    Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines by Vladimír Šubr, Robert Pola, Shanghui Gao, Rayhanul Islam, Takuma Hirata, Daiki Miyake, Kousuke Koshino, Jian-Rong Zhou, Kazumi Yokomizo, Jun Fang, Tomáš Etrych

    Published 2022-04-01
    Get full text
    Article
  7. 7
    Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms

    Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms by Klára Pospíšilová, Tomáš Knedlík, Pavel Šácha, Libor Kostka, Jiří Schimer, Jiří Brynda, Vlastimil Král, Petr Cígler, Václav Navrátil, Tomáš Etrych, Vladimír Šubr, Michael Kugler, Milan Fábry, Pavlína Řezáčová, Jan Konvalinka

    Published 2019-04-01
    Get full text
    Article
  8. 8
    Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.

    Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. by Lieselotte Vande Walle, Irma B Stowe, Pavel Šácha, Bettina L Lee, Dieter Demon, Amelie Fossoul, Filip Van Hauwermeiren, Pedro H V Saavedra, Petr Šimon, Vladimír Šubr, Libor Kostka, Craig E Stivala, Victoria C Pham, Steven T Staben, Sayumi Yamazoe, Jan Konvalinka, Nobuhiko Kayagaki, Mohamed Lamkanfi

    Published 2019-10-01
    Get full text
    Article

Search Tools: